BioSpace News Archive

The Company announces that it has raised NOK 242,525,624 in gross proceeds through a private placement of 11,023,892 new shares The Private Placement was completed at a subscription price of NOK 22.00 per share, which was determined through an accelerated book-building process.

Reference is made to the announcement by Nordic Nanovector ASA on 18 October 2019 concerning a private placement with gross proceeds in the amount of NOK 242 525 624 and that the Company is considering to conduct a repair offering of up to 2,204,778 new shares with non-tradeable subscription rights to eligible shareholders.

The market will accelerate at a CAGR of over 4% between 2019-2023

Globe Life Inc. will release Third Quarter 2019 earnings after the market closes on Wednesday, Oct. 23 2019.

The market will accelerate at a CAGR of over 5% between 2019-2023

Merck announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending a conditional marketing authorization for V920 Ebola Zaire vaccine If affirmed by the European Commission, the vaccine will be authorized under the brand name ERVEBO® and indicated for active immunization of individuals 18 years of age or older to protect against Ebola Virus Disease caused by Zaire Ebola virus.

Foamix Pharmaceuticals Ltd., a specialty pharmaceutical company, announced that the U.S. Food and Drug Administration has approved its novel AMZEEQTM topical foam, 4%.

At 26 weeks, 54% of adults and 71% of children treated with ULTOMIRIS demonstrated Complete Thrombotic Microangiopathy (TMA) Response

Cytovance® Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced the company will participate in the upcoming Recent Advances in Fermentation Technology Conference to be held October 29 - November 1, 2017 at the Hyatt Coconut Point, Bonita Springs, Florida.

Oxford-based start-up Ultromics has announced the appointment of Amir Hasan as Chief Commercial Officer